Dianthus Therapeutics Inc. (DNTH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.04B
Last updated: Nov 17, 2026 at 4:15 PM ET
Dianthus Therapeutics Inc. (DNTH) Stock Chart
Dianthus Therapeutics (DNTH) has a latest price of $86.98 on Nov 17, 2026, 26.2% below its 52-week high of $117.88. Its price rose 112.9% over the past 12 months. The month-end price rose 586.5% over the 3 years through Oct 2026, a compound annual rate of 90.1%.
Price Chart
From Sep 2023 to Oct 2026, its highest month-end close was $106.92 in Jul 2026 and its lowest $10.40 in Dec 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DNTH with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DNTH.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 23.5%, and over 6 months it rose 1.5%.
| Period | Change |
|---|---|
| 1 month | +16.7% |
| 3 months | -23.5% |
| 6 months | +1.5% |
| 12 months | +112.9% |
| 12 months, with dividends | +112.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +586.5% | +90.1% |
Price by Year
Its best calendar year was 2024, when the price rose 109.6%, and its weakest was 2025, when it rose 89.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $82.38 | +99.9% |
| 2025 | $41.21 | +89.0% |
| 2024 | $21.80 | +109.6% |
Trading Range
The price is 0.7% below its 50-day average of $87.64 and 0.3% below its 200-day average of $87.27.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $86.98 | |
| 52-week high | $117.88 | -26.2% |
| 52-week low | $35.84 | +142.7% |
| 50-day average | $87.64 | -0.7% |
| 200-day average | $87.27 | -0.3% |
Price Risk
Over 3 years, its largest fall from a peak was 53.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.99 |
| Largest fall, 1 year | -37.8% |
| Largest fall, 3 years | -53.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DNTH
What is DNTH's 1-year price change?
Dianthus Therapeutics's price rose 112.9% over the past 12 months. With dividends included, the 12-month total return was 112.9%.
How has DNTH stock done over the long term?
Dianthus Therapeutics's month-end price rose 586.5% over the 3 years through Oct 2026, a compound annual rate of 90.1%. These figures leave out dividends.
What is DNTH's 52-week high and low?
Dianthus Therapeutics's 52-week high is $117.88 and its 52-week low is $35.84. Its latest price of $86.98 on Nov 17, 2026 is 26.2% below the high.
What is DNTH's beta?
Dianthus Therapeutics's 1-year beta against the S&P 500 is 0.99, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 37.8%.
Is the DNTH chart free?
Yes. Advanced Charting for DNTH is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DNTH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors